Results 271 to 280 of about 128,640 (296)

Glucagon-Like Peptide-1

2010
openaire   +1 more source

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Lancet, The, 2006
Daniel J Drucker, Michael A Nauck
exaly  

Glucagon-like-peptide-1

Reactions Weekly, 2014
openaire   +1 more source

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

Lancet, The, 2014
Bernard Zinman Cm, Ravi Retnakaran, Caroline K Kramer   +2 more
exaly  

[Glucagon-like peptide-1(GLP-1)].

Nihon rinsho. Japanese journal of clinical medicine, 2004
Glucagon-like peptide-1(GLP-1), an intestinal hormone secreted by L cells in response to luminal nutrients(carbohydrate and fat), enhances glucose-induced insulin secretion. Impairment of glucose-induced insulin secretion in patients with type 2 diabetes can be restored to near-normal by GLP-1 administration.
openaire   +1 more source

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

New England Journal of Medicine, 1992
Jens J Holst Dmsci, Bo Ahrén
exaly  

Glucagon-like peptide-1

Trends in Endocrinology & Metabolism
openaire   +2 more sources

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

Cell Metabolism, 2018
Daniel J Drucker
exaly  

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

Circulation, 2019
Stephen Wiviott, Itamar Raz, Marc P Bonaca   +2 more
exaly  

A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity

Circulation, 2013
Ilya M Mukovozov, Ren-Ke Li, Filio Billia   +2 more
exaly